92 related articles for article (PubMed ID: 25757918)
1. Evaluation of antitumor effects of folate-conjugated methyl-β-cyclodextrin in melanoma.
Motoyama K; Onodera R; Tanaka N; Kameyama K; Higashi T; Kariya R; Okada S; Arima H
Biol Pharm Bull; 2015; 38(3):374-9. PubMed ID: 25757918
[TBL] [Abstract][Full Text] [Related]
2. Induction of mitophagy-mediated antitumor activity with folate-appended methyl-β-cyclodextrin.
Kameyama K; Motoyama K; Tanaka N; Yamashita Y; Higashi T; Arima H
Int J Nanomedicine; 2017; 12():3433-3446. PubMed ID: 28496320
[TBL] [Abstract][Full Text] [Related]
3. Folate-Appended Hydroxypropyl-β-Cyclodextrin Induces Autophagic Cell Death in Acute Myeloid Leukemia Cells.
Kubota Y; Hoshiko T; Higashi T; Motoyama K; Okada S; Kimura S
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069042
[TBL] [Abstract][Full Text] [Related]
4. Involvement of autophagy in antitumor activity of folate-appended methyl-β-cyclodextrin.
Onodera R; Motoyama K; Tanaka N; Ohyama A; Okamatsu A; Higashi T; Kariya R; Okada S; Arima H
Sci Rep; 2014 Mar; 4():4417. PubMed ID: 24646866
[TBL] [Abstract][Full Text] [Related]
5. [Development of Cyclodextrin-based Cancer Treatment].
Motoyama K
Yakugaku Zasshi; 2015; 135(11):1291-8. PubMed ID: 26521878
[TBL] [Abstract][Full Text] [Related]
6. Dual targeting system by supramolecular complex of folate-conjugated methyl-β-cyclodextrin with adamantane-grafted hyaluronic acid for the treatment of colorectal cancer.
Elamin KM; Motoyama K; Higashi T; Yamashita Y; Tokuda A; Arima H
Int J Biol Macromol; 2018 Jul; 113():386-394. PubMed ID: 29486262
[TBL] [Abstract][Full Text] [Related]
7. Potential use of folate-appended methyl-β-cyclodextrin as an anticancer agent.
Onodera R; Motoyama K; Okamatsu A; Higashi T; Arima H
Sci Rep; 2013; 3():1104. PubMed ID: 23346361
[TBL] [Abstract][Full Text] [Related]
8. Involvement of cholesterol depletion from lipid rafts in apoptosis induced by methyl-β-cyclodextrin.
Onodera R; Motoyama K; Okamatsu A; Higashi T; Kariya R; Okada S; Arima H
Int J Pharm; 2013 Aug; 452(1-2):116-23. PubMed ID: 23684659
[TBL] [Abstract][Full Text] [Related]
9. Folate-appended β-cyclodextrin as a promising tumor targeting carrier for antitumor drugs in vitro and in vivo.
Okamatsu A; Motoyama K; Onodera R; Higashi T; Koshigoe T; Shimada Y; Hattori K; Takeuchi T; Arima H
Bioconjug Chem; 2013 Apr; 24(4):724-33. PubMed ID: 23458386
[TBL] [Abstract][Full Text] [Related]
10. Potential use of the complex of doxorubicin with folate-conjugated methyl-β-cyclodextrin for tumor-selective cancer chemotherapy.
Motoyama K; Onodera R; Okamatsu A; Higashi T; Kariya R; Okada S; Arima H
J Drug Target; 2014 Oct; 22(3):211-219. PubMed ID: 24219311
[TBL] [Abstract][Full Text] [Related]
11. Characterization and evaluation of a folic acid receptor-targeted cyclodextrin complex as an anticancer drug delivery system.
Xu J; Xu B; Shou D; Qin F; Xu Y; Hu Y
Eur J Pharm Sci; 2016 Feb; 83():132-42. PubMed ID: 26577995
[TBL] [Abstract][Full Text] [Related]
12. Design and evaluation of folate-appended α-, β-, and γ-cyclodextrins having a caproic acid as a tumor selective antitumor drug carrier in vitro and in vivo.
Okamatsu A; Motoyama K; Onodera R; Higashi T; Koshigoe T; Shimada Y; Hattori K; Takeuchi T; Arima H
Biomacromolecules; 2013 Dec; 14(12):4420-8. PubMed ID: 24175976
[TBL] [Abstract][Full Text] [Related]
13. Carboxymethyl-β-cyclodextrin conjugated nanoparticles facilitate therapy for folate receptor-positive tumor with the mediation of folic acid.
Su C; Li H; Shi Y; Wang G; Liu L; Zhao L; Su R
Int J Pharm; 2014 Oct; 474(1-2):202-11. PubMed ID: 25149123
[TBL] [Abstract][Full Text] [Related]
14. Folic Acid-Appended Hydroxypropyl-β-Cyclodextrin Exhibits Potent Antitumor Activity in Chronic Myeloid Leukemia Cells via Autophagic Cell Death.
Hoshiko T; Kubota Y; Onodera R; Higashi T; Yokoo M; Motoyama K; Kimura S
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771576
[TBL] [Abstract][Full Text] [Related]
15. Involvement of PI3K-Akt-Bad pathway in apoptosis induced by 2,6-di-O-methyl-beta-cyclodextrin, not 2,6-di-O-methyl-alpha-cyclodextrin, through cholesterol depletion from lipid rafts on plasma membranes in cells.
Motoyama K; Kameyama K; Onodera R; Araki N; Hirayama F; Uekama K; Arima H
Eur J Pharm Sci; 2009 Oct; 38(3):249-61. PubMed ID: 19664706
[TBL] [Abstract][Full Text] [Related]
16. Folate-appended cyclodextrin carrier targets ovarian cancer cells expressing the proton-coupled folate transporter.
Saito S; Koya Y; Kajiyama H; Yamashita M; Kikkawa F; Nawa A
Cancer Sci; 2020 May; 111(5):1794-1804. PubMed ID: 32154964
[TBL] [Abstract][Full Text] [Related]
17. Supramolecular Complex of Methyl-β-cyclodextrin with Adamantane-Grafted Hyaluronic Acid as a Novel Antitumor Agent.
Elamin KM; Yamashita Y; Higashi T; Motoyama K; Arima H
Chem Pharm Bull (Tokyo); 2018 Mar; 66(3):277-285. PubMed ID: 29269686
[TBL] [Abstract][Full Text] [Related]
18. Folate receptor-specific antitumor activity of EC131, a folate-maytansinoid conjugate.
Reddy JA; Westrick E; Santhapuram HK; Howard SJ; Miller ML; Vetzel M; Vlahov I; Chari RV; Goldmacher VS; Leamon CP
Cancer Res; 2007 Jul; 67(13):6376-82. PubMed ID: 17616697
[TBL] [Abstract][Full Text] [Related]
19. Folic acid-coupled nano-paclitaxel liposome reverses drug resistance in SKOV3/TAX ovarian cancer cells.
Tong L; Chen W; Wu J; Li H
Anticancer Drugs; 2014 Mar; 25(3):244-54. PubMed ID: 24275314
[TBL] [Abstract][Full Text] [Related]
20. The antitumor effects of methyl-β-cyclodextrin against primary effusion lymphoma via the depletion of cholesterol from lipid rafts.
Gotoh K; Kariya R; Alam MM; Matsuda K; Hattori S; Maeda Y; Motoyama K; Kojima A; Arima H; Okada S
Biochem Biophys Res Commun; 2014 Dec; 455(3-4):285-9. PubMed ID: 25446086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
